Cyrus Harmon sold $269K of Olema Pharmaceuticals (OLMA)

Executed Jan 20, disclosed Jan 21, 1 day later.

Value, as filed

$269K

10,000 sh × $26.88

Executed

Jan 20

the trade date, as filed

Disclosed

Jan 21

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CH Cyrus Harmon Director profile →

Cyrus Harmon (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Olema Pharmaceuticals, Inc. (OLMA). The largest single filing was $291K of OLMA (25,000 sh across 2 lots, as filed), executed Jul 23.

The name

OLMA Olema Pharmaceuticals, Inc. OLMA · Healthcare · 17 filings in 24 months ticker →

Healthcare · Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of th…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Cyrus Harmon in OLMA

OLMASALE Olema Pharmaceuticals, Inc. $291K
25,000 sh across 2 lots
Exec Jul 23
Filed Jul 27 · 7:30 PM ET OLMASALE Olema Pharmaceuticals, Inc. $102K
3,489 sh × $29.12
Exec Jan 14
Filed Jan 16 · 5:30 PM ET